Monoclonal antibodies are a class of medicines that have transformed the way we prevent and treat diseases, from cancer and diseases of the immune system to childhood viral infections. They are not chemical compounds, as most drugs are.
They are based on natural antibodies which are proteins that the body produces to defend itself against disease but are created in the lab and mass-produced in factories. This is why they’re sometimes called ‘designer antibodies’ they are tailor-made to the disease they treat. If you want to know more about antibodies, you can also browse https://www.bosterbio.com/featured-products.
The first monoclonal antibody product was licensed more than 30 years ago. Since then, millions of people have benefitted from more than 100 such treatments. Around 50 of these were brought to market in the past six years alone.
Image Source: Google
This is one of the fastest-growing fields in biomedical research, and an increasingly important segment of the pharmaceutical market – last year, seven of the top 10 best-selling drugs were monoclonal antibodies.
Antibodies are proteins produced by our immune system and are one of the main ways the body defends itself against diseases.
They work by binding to their specific targets – for example, viruses, bacteria, or cancerous cells – and making them harmless. They block the action of the target, or they flag it as foreign so that other parts of our immune system can clear the ‘invaders’ away. Monoclonal antibodies work in the same way too.